Constitutive degradation of PML/RARα through the proteasome pathway mediates retinoic acid resistance

Blood

Volumn 93, Issue 5, 1999, Pages 1477-1481

  Fanelli, Mirco ^b   Minucci, Saverio ^b   Gelmetti, Vania ^b   Nervi, Clara ^b   Gambacorti Passerini, Carlo ^b   Pelicci, Pier Giuseppe ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LACTACYSTIN; PROTEASOME; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LEUKEMOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0033104901     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1477     Document Type: Article

References (25)

1. Warrel RP Jr, de The H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
2. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
3. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ: Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood 89:376, 1997
4. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM: A PML/RARα transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:2551, 1997
5. He L-Z, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP: Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA 94:5302, 1997
6. Grignani Fr, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG: Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion of PML protein dimerization and RARα DNA binding domains. EMBO J 15:4949, 1996
7. Chomienne C, Fenaux P, Degos L: Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 10:1025, 1996
8. Nervi C, Ferrara FF, Fanelli M, Rippo MR, Tomassini B, Ferrucci PF, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani Fr, Pelicci PG, Testi R: Caspases mediate retinoic acid induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein. Blood 92:2244, 1998
9. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T: Accelerated degradation of PML-retinoic acid receptor α (PML/RARα) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway. Cancer Res 56:2945, 1996
10. Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr: The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88:2826, 1996
11. Grignani Fr, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
12. Grignani Fr, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthard M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG: Fusion proteins of retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815, 1998
13. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM: Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811, 1998
14. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F: Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell' Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 90:1014, 1997
15. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood 82:1573, 1993
16. Dermime S, Grignani F, Rogaia D, Liberatore C, Marchesi E, Gambacorti-Passerini C: Acute promyelocytic leukemia cells resistant to retinoic acid show further perturbation of the RARα signal transduction system. Leuk Lymphoma 16:289, 1995
17. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner Ph, Berger R, Lanotte M: A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, and molecular features. Leukemia 6:1281, 1992
18. Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH Jr: A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. Blood 89:4282, 1997
19. Gaub MP, Lutz Y, Ruberte E, Petkovich M, Brand N, Chambon P: Antibodies specific to the retinoic acid human nuclear receptors alpha and beta. Proc Natl Acad Sci USA 86:3089, 1989
20. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF, Pelicci PG, Falini B: Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells and epithelia. Blood 85:1871, 1995
21. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML/RARα-mediated increase of type II transglutaminase. Blood 87:1939, 1996
22. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG: High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 58:14, 1998
23. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
24. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr: Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124, 1998
25. Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE: Leukemic cellular retinoic acid resistance and missence mutations in the PML/RAR alpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood 92:1172, 1998